Pasithea Therapeutics Corp's total assets for Q3 2025 were $13.63M, a decrease of -19.86% from the previous quarter. KTTA total liabilities were $1.42M for the fiscal quarter, a -22.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.